This part of the site is strictly dedicated to healthcare professionals practicing in malarial endemic areas

MALARIA NEWS

Information and Training


Submit Advanced search
     


[08/04/2005]
 Mali
 < Back to the list 


Authors: Dr Francis Louis, Yaoundé, Cameroon –    
Acknowledgements : Pr Abdourahamane Sideye MAIGA, I.N.R.S.P., Bamako, Mali




> General Statistics | > Epidemiological Facies | > Vectors | > Chemoresistance | > The National Anti Malaria Program | > Research Institutions. | > Advice to travelers | > Bibliography

 General Statistics

Area: 1,241,133 km²
Population: 10,800,000 inhabitants
Capital:  Bamako
Currency:  CFA franc (1 FCFA = 0,01 FF)
Official Language:  French
Bordering countries: Algeria, Niger, Burkina Faso, Ivory Coast, Guinea, Senegal and Mauritania  

Out of 192 countries Mali ranks 184th for life expectancy, 190th for infant mortality, 176th for GNP, 139th for daily calorie intake, 181st for literacy, 170th for the percentage of children in full-time education (source: Atlas Encyclopédique Mondial, Nathan Ed., Paris 1996, pp.118-119). 

Concerning   climate, Mali can be divided into two parts:

The South, characterized by a rainy season from May to October, with maximum rainfall in August.
The north, above 16° of latitude, where the climate is desert-like.
The map below shows the isohyets   (S. Maiga, comm. pers.): 

 Epidemiological Facies

1. South of 16° latitude north, malaria is of the sahelian type: this means that transmission is seasonal and short from June to November and that relative immunity takes a long time to acquire. During the rainy season malaria is at the origin of more than 2/3 cases of fever (S. Maiga, comm. pers.).  
In 1942, in this part of Mali, the splenic   rate was at   56.2% in the 2-5 years old age group; 45.7% in 6-10 year olds, and at 32.4% in 11-15 year olds (1). Plasmodiumfalciparum represented 95% of identified hematozoon, the remaining 5% were divided between Plasmodium ovale and Plasmodiummalariae (1 ). 

In practice however, the malaria situation varies from one area to another. These variations are linked to the presence, or not, of a river (Niger, Senegal, Bani) and to ecological systems: a mosaic of savannah-forest in the   extreme south,   savannah and trees in the Bamako region, flood plains the length of the river Niger, steppes and shrubs to the west etc. According to A. Escudié and J. Hamon, schematically we can consider there being a gradient from the west (mesoendemic, i.e.the parasite prevalence rate is between 11 and 50% in 2-9 year olds) to the east (holoendemic, i.e. the parasite prevalence rate is superior to 75% in children aged under 1) (2). In a recent study, I. Kleinschmidt et al. stated the exact opposite: that the risk is far greater in the west than in the east ... (41 ). 

In 1977, E. Ngombé found a parasite prevalence rate in Bamako of 70% in children aged under 10. Plasmodiumfalciparum was found in 94% of cases (7). These findings were confirmed in 1978 by P. Ballester (9 ). 

Also in 1978, the study of 938 school children aged between 6 and 18, south of Bamako, showed a parasite prevalence rate of 70.5% and Plasmodiumfalciparum was found in 94.4% cases, Plasmodiummalariae in 6.2% and Plasmodiumovale in 3.6% (8 ). 

In 1980 in,Kambila, 25 km north of Bamako, the plasmodium prevalence rate was at 73.6% in children aged under 9 and  Plasmodiumfalciparum was found in 95.7% cases (10 ). 

Further north, at the very limit of 16° latitude north the plasmodium prevalence rate was at 63% in the general population even though it was not the rainy season (11).In 1989, the plasmodium prevalence rate varied from 35.4% in May to 61.9% in November in Tieneguebougou and from 54.3% to 75.1% in Kambila, two villages   at 15 km from Bamako (12 ).  

2. In the north, malaria strikes periodically, and is inconsistent from one year to another.

 Vectors

In 1943, J. Sautet and H. Marneffe identified the vectors Anopheles coustani, Anopheles paludis similis, Anopheles funestus, Anopheles gambiae, Anopheles pharoensis Anopheles rufipes rufipes and Anopheles squamosus (1 ), with a huge predominance of Anopheles gambiae. 
In 1960, A. Escudié and J. Hamon pointed out that Anopheles funestus  dominated during the dry season and that, Anopheles gambiae and Anopheles nili were dominant during the rainy season (2 ). 
Jacques Brunhes et al.(Les anophèles de la région afro-tropicale, logiciel ORSTOM Ed., 1998) registered    23 different species of anopheles in the country, of varing medical interest: Anopheles arabiensis, Anopheles brohieri, Anopheles brunnipes, Anopheles coustani, Anopheles domicola, Anopheles flavicosta, Anopheles funestus, Anopheles gambiae, Anopheles hancocki, Anopheles leesoni, Anopheles maculipalpis, Anopheles nili, Anopheles obscurus, Anopheles paludis, Anopheles pharoensis, Anopheles pretoriensis, Anopheles rhodesiensis rhodesiensis, Anopheles rivulorum, Anopheles rufipes rufipes, Anopheles sergentii macmahoni, Anopheles squanosus, Anopheles wellcomei wellcomei and Anopheles ziemanni. 

 Chemoresistance

1. Resistance to chloroquine. 

The first case of reduced sensitivity to chloroquine was brought to light in 1987 during an in vivo test on 43 school children in Selingue, 150 km south of Bamako (28).
The first case of chloroquine-resistance was published in 1988 (14), the second in 1990 (16). That same year, Guiguemde proved the phenomenon again, in vivo, in Bamako at a rate of 7% (2 cases of resistance out of 29 children asymptomatic carriers, treated with   chloroquine) (19 ).
Since 1991, nothing more has been published on the subject. The « Pr Maïga » documents the 2 year study of 2,300 children from the same village: 19.3% were resistant to chloroquine in 1996 and 21.5% in 1997 (comm. pers.). In the same village, the rate of drug trial failure was 10.1% in 1996 and 7.3% in 1997. 

2. Resistance to other antimalarial drugs:

Amodiaquine: not documented 
Quinine: not documented 
Sulfadoxine-pyrimethamine combination: a 1996 study conducted in Bandiagara showed that of 89 samples, 3 had the genotype of resistance to pyrimethamine only (3.4%) and 9 of mixed infections (10.1%). In Mopti, out of 77 samples tested, 2 showed resistance to pyrimethamine (2.6%) and 16 were of mixed infections (20.8%) (26 ). 
Proguanil: Out of a total of 501 strains of plasmodium collected from malaria sufferers upon their return from Africa between 1995 and 1997, of which 59 came from Mali, R. Durand et al. showed a rate of mutation of codon 108 of the parasite gene by dihydrofolate-reductase pass from 19.8% in 1995 (81 strains tested) to 43.6% in 1997 (259 strains tested). Unfortunately, the authors only gave general results and not individual ones for each of the 29 countries involved (38).

 The National Anti Malaria Program
If such a program does exist today, it is without a leader. 

According to Y. Kassankogno, the main action plan of the program is the setting up of policies on the management of cases and the use of treated mosquito nets (39). Nevertheless there is only one documented trial which ran from 1989-1990 and concerned curtains treated with permethrine (17).
 Research Institutions.
The Pr. Ogobara Doumbo (Medicine Faculty in Bamako) and Abdourahamane Sideye Maïga (I.N.R.S.P.) are in the process of conducting malaria research in Mali. Their main area of research is the study of in vivo and in vitro chemoresistance , the monitoring of failed drug trials, and compliance to the therapeutic schedule by patients and drug prescribers alike, within the CAP studies concerning Anti Malaria Action on a community based level. (A.S. Maïga, comm. pers.). 
 Advice to travelers
According to the B.E.H. n°24-25 of the 14th june 2005, Mali is classified in chloroquine-resistance group II . This signifies that a traveler spending less than 3 months in the country should take the Chloroquine-Proguanil or the Atovaquone-Proguanil combined treatment

This recommendation seems totally appropriate for someone traveling to the south of the country. However, for the rest of the country, that’s to say north of the Tombouctou-Gao line the specific conditions of the journey should be taken into account: humid season Vs dry ? Staying in towns or in the countryside ? Staying at a hotel or in a traditional dwelling? etc . More often, simple measures of precaution against mosquito bites seem to be sufficient.
 Bibliography

1. SAUTET J., MARNEFFE H. - Notes sur le paludisme, la bilharziose intestinale, les teignes, etc., au Soudan Français. Med. Trop. 1943 ; 3: 333-367.

2. ESCUDIE A., HAMON J. - Le paludisme en Afrique occidentale d'expression française. Med. Trop. 1961 ; 20: 661-687.

3. ROUGEMONT A., QUILICI M., RANQUE P., PENE P. - Taux d'haptoglobine, paludisme et anémie chez l'adulte africain.  Bull. Soc. Path.  Exot. 1974 ; 67: 53-57.

4. ROUGEMONT A., QUILICI M., RANQUE P., PENE P. - Taux d'haptoglobine, paludisme et anémie chez l'adulte africain. Résultats complémentaires, perspectives et problèmes méthodologiques.  Bull. Soc. Path.  Exot. 1974 ; 67: 370-377.

5. ROUGEMONT A., BOISSON M.E., DOMPNIER J.P. et Coll. - Paludisme et anémie de la grossesse en zone de savane africaine. Etude épidémiologique, hématologique, biologique et immunologique dans deux villages de la région de Bamako, République du Mali.  Bull. Soc. Path.  Exot. 1977 ; 70: 265-273.

6. LLORET F. - Modifications biologiques, parasitologiques et immunologiques chez les adultes après un an de chimioothérapie de masse par la chloroquine dans un village d'hyperendémie palustre dans la région de Bamako au Mali. Thèse médecine, Marseille 1977, 38 p.

7. NGOMBE J-E. - Incidence de la chimiothérapie antipaludique sur l'état de santé d'une population rurale au Mali. Thèse médecine, Marseille 1979, 98 p.

8. CHABASSE D., DUMON H., TOUNKARA A.et Coll. - Indices paludométriques chez 938 enfants et adolescents en savane humide au sud du Mali.  Bull. Soc. Path.  Exot. 1980 ; 73: 254-258.

9. BALLESTER P. - Influence d'une chimioprophylaxie sur les indices paludométriques d'une population rurale en savane soudanienne au Mali. Thèse médecine, Marseille 1981, 110 p.

10. DELMONT J., RANQUE P., BALIQUE H. et Coll. - Influence d'une chimioprophylaxie antipaludique sur l'état de santé d'une communauté rurale en Afrique de l'Ouest. Résultats préliminaires. Bull. Soc. Path. Exot. 1981 ; 74: 600-610.

11. CHABASSE D., ROURE C., AG RHALY A. et Coll. - Evaluation de l'état sanitaire des populations nomades et semi-nomades du Gourma-Mali. Approche épidémiologique.II. Résultats globaux et conclusion.  Med. Trop. 1983 ; 43: 127-135.

12. MAIGA A.S., BRINKMANN A. - Risk in a national malaria control programme in Mali: underdosage of antimalarials. Trop. Med. Parasitol. 1987 ; 38: 333-334.

13. MILLER K.D., CAMPBELL G.H., NUTMAN T.B. et Coll. - Early acquisition of antobody to Plasmodium falciparum sporozoites in non immune temporary residents of Africa.  J. Infect. Dis. 1988 ; 158: 868-871.

14. CHABASSE D., DE GENTILE L., LIGNY C. et Coll. - Chloroquine-resistant Plasmodium falciparum in Mali revealed by congenital malaria. Trans. R. Soc. Trop. Med. Hyg. 1988 ; 82: 547.

15. Ambassade de France à Bamako, Mission de coopération et d'Action Culturelle - Mali. Notice d'information à l'usage des assistants techniques. Monographie Ministère de la Coopération et du développement 1990 ; 80 pages.

16. IPSEVITCH F., MISSONI E. - A case of Plasmodium falciparum malaria from Mali: failure of chloroquine chemoprophylaxis.  Trop. Doctor 1990 ; 20: 170.

17. DOUMBO O., TRAORE S.F., SOW Y. et Coll. - Impact des rideaux et couvertures imprégnés de perméthrine sur les indices paludométriques et le nombre d'accès palustres par enfant dans un village d'hyperendémie palustre de savane malienne (résultats préliminaires de la première année d'étude). Bull. Soc. Path. Exot. 1991 ; 84: 761-774.

18. ROUGEMONT O., BRESLOW N., BRENNER E. et Coll. - Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa.  Lancet 1991 ; 338: 1292-1295.

19. GUIGUEMDE T.R., GBARY A.R., OUEDROGO J-B. et Coll. - Point actuel sur la chimiorésistance du paludisme des sujets autochtones dans les Etats de l'OCCGE (Afrique de l'Ouest). Ann. Soc. belge Med. trop. 1991 ; 71: 199-207.

20. HAIDARA S.A., DOUMBO O., TRAORE H.A. et Coll. - La place du paludisme dans des syndromes fébriles en médecine interne à l'Hôpital du Point G. Med. Afr. Noire 1991 ; 38: 110-117.

21. DOUMBO O., TOURE A., COULIBALY B. et Coll. - Incidence du paludisme et hémoglobinose S en milieu hospitalier pédiatrique bamakois au Mali. Med. Trop. 1992 ; 52: 169-174.

22. DOUMBO O., DOUCOURE O., KOITA O. et Coll. - Efficacité et tolérance de la triple association méfloquine-sulphadoxine-pyriméthamine (Fansimef®) dans le traitement des accès palustres graves à Plasmodium falciparum au Mali (à propos de 100 cas). Med. Afr. Noire 1992 ; 39: 458-462. 

23. TOLLE R.K., FRUTH O., DOUMBO O. et Coll. - A prospective study of the association between the human humoral response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect. Immun. 1993 ; 61: 40-47.

24. TOURE Y.T., PETRARCA V., TRAORE S.F. et Coll. - Ecological genetic studies in the chromosomal form Mopti of Anopheles gambiae s.s. in Mali, West Africa. Genetica 1994 ; 94: 213-223.

25. PLOWE C.V., DJIMDE A., BOUARE M. et Coll. - Pyrimethamine and proguanil resistance conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.  Am. J. Trop. Med. Hyg. 1995 ; 52: 565-568.

26. PLOWE C.V., DJIMDE A., WELLEMS T.E. et Coll. - Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodiumfalciparum genotypes in Mali: a model for detecting resistance.  Am. J. Trop. Med. Hyg. 1996 ; 55: 467-471.

27. BOUARE M., SANGARE D., BAGAYOKO M. et Coll. - Simultaneous detection by polymerase chain reaction of mosquito species and Plasmodiumfalciparum infection in Anopheles gambiae sensu lato.  Am. J. Trop. Med. Hyg. 1996 ; 54: 629-631.

28. MAIGA A.S. - La lutte antipaludique vue dans une approche intégrée de la prise en charge de l'enfant fébrile en Afrique sub-saharienne.  Malaria and Infectious Diseases in Africa 1996 ; n°4: 4-5.

29. PLOWE C.V., CORTESE J.F., DJIMDE A. et Coll. - Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthetase and epidemiologic patterns of pyrimathamine-sulfadoxine use and resistance. J. Inf. Dis. 1997 ; 176: 1590-1596.

30. GUINET F., DIALLO D.A., MINTA D. et Coll. - A comparison of the incidence of severe malaria in Malian children with normal and C-trait hemoglobin files. Acta Trop. 1997 ; 68: 175-182.

31. BOUVIER P., ROUGEMONT A., BRESLOW N. et Coll. - Seasonality and malaria in a west african village: does high parasite density predict fever incidence ?  Am. J. Epidemiol.  1997 ; 145: 850-857.

32. BOUVIER P., DOUMBO O., BRESLOW N. et Coll. - Seasonality, malaria, and impact of prophylaxis in a west African village. I. Effect on anemia in pregnancy.  Am. J. Trop. Med. Hyg. 1997 ; 56: 378-383.

33. BOUVIER P., BRESLOW N., DOUMBO O. et Coll. - Seasonality, malaria, and impact of prophylaxis in a west African village. II. Effect on birthweight.  Am. J. Trop. Med. Hyg. 1997 ; 56: 384-389.

34. PETRARCA V., SABATINELLI G., TOURE Y.T., DI DECO M.A. - Morphometric multivariate analysis of field samples of adult Anopheles arabiensis and Anopheles gambiae s.s. (Diptera: Culicidae). J. Med. Entomol. 1998 ; 35: 16-25.

35. ROBSON K.J.H., DOLO A., HACKFORD I.R. et Coll. - Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodiumfalciparum.  Am. J. Trop. Med. Hyg. 1998 ; 59: 81-89.

36. DJIMDE A., PLOWE C.V., DIOP S. et Coll. - Use of antimalarial drugs in Mali: policy versus reality.  Am. J. Trop. Med. Hyg. 1998 ; 59: 376-379.

37. TOURE Y.T., DOUMBO O., TOURE A. et Coll. - Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali, as a transmission-blocking vaccine site.  Am. J. Trop. Med. Hyg. 1998 ; 59: 481-486.

38. DURAND R., DI PIAZZA J-P., LONGUET C. et Coll. - Incresed incidence of cycloguanil resistance in malaria cases entering France from Africa, determined as point mutations in the parasites'dihydrofolate-reductase genes.  Ann. Trop. Med. Parasitol. 1999 ; 93: 25-30.

39. KASSANKOGNO Y. - Aperçu sur le programme de lutte contre le paludisme africain pour la période 1996-1997.  Malaria and Infectious Diseases in Africa 1999 ; n°9bis: 52-61.

40. DELLEY V., BOUVIER P., BRESLOW N. et Coll. - What does a single determination of malaria parasite density mean ? A longitudinal survey in Mali. Trop. Med. Parasitol. 2000 ; 5: 404-412.

41. KLEINSCHMIDT I., BAGAYOKO M., CLARKE G.P.Y. et Coll. - A spatial statistical approach to malaria mapping.  Int. J. Epidemiol.  2000 ; 29: 355-361.

42. AGARWAL A., GUINDO A., CISSOKO Y. et Coll. - Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a west African population with a low prevalence of hemoglobin S. Blood 2000 ; 96: 2358-2363.

43. TRAORE M. - Etre médecin de campagne au Mali. A propos de l'expérience du docteur N'Dao N'Débougou. Mémoire de D.E.A., option anthropologie bio-culturelle, Université Aix-Marseille, 2000, 70 pages + annexes.

44. STENGER S. - Comportements et attitudes pratiques des expatriés vis-à-vis du paludisme dans six pays d'Afrique. Mémoire D.U. médecine et santé publique tropicales, Université Aix-Marseille, 2000, 30 pages.

 

© Copyright sanofi-aventis 2002-2008 all rights reserved
Disease information about malaria:the parasite, the symptoms, prevention and treatment options, atlas of malaria, etc.